Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #Daniel J. Tenney, Richard J. Colonno, Ronald E. Rose et al.|Hepatology|2009Cited by 815
A Novel Small Molecule Inhibitor of Hepatitis C Virus EntryCarl J. Baldick, Daniel J. Tenney, Ann W. Walsh et al.|PLoS Pathogens|2010Cited by 82
W1805 Entecavir Maintains a High Genetic Barrier to HBV Resistance Through 6 Years in NaïVE PatientsDaniel J. Tenney, Uchenna H. Iloeje, Kevin A. Pokornowski et al.|Gastroenterology|2009Cited by 25
Discovery of Potent, Dual-Inhibitors of Diacylglycerol Kinases Alpha and Zeta Guided by Phenotypic OptimizationLouis Chupak, Susan Wee, Michael Wichroski et al.|ACS Medicinal Chemistry Letters|2023Cited by 21
Ultrasensitive Genotypic Detection of Antiviral Resistance in Hepatitis B Virus Clinical IsolatesJie Fang, Daniel J. Tenney, Michael Wichroski et al.|Antimicrobial Agents and Chemotherapy|2009Cited by 12